Literature DB >> 30538205

Molecular link between itch and atopic dermatitis.

Tiphaine Voisin1, Isaac M Chiu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30538205      PMCID： PMC6304981          DOI： 10.1073/pnas.1818879115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

Review 1.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 2.  Atopic dermatitis treatment: Current state of the art and emerging therapies.

Authors:  Jonathan I Silverberg
Journal:  Allergy Asthma Proc       Date:  2017-07-01       Impact factor: 2.587

3.  Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch.

Authors:  Joshua J Emrick; Anubhav Mathur; Jessica Wei; Elena O Gracheva; Karsten Gronert; Michael D Rosenblum; David Julius
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

4.  Glutathione S-transferase M1 (GSTM1) polymorphism is associated with atopic dermatitis susceptibility in a Korean population.

Authors:  H-R Cho; Y-K Uhm; H-J Kim; J-Y Ban; J-H Chung; S-V Yim; B-K Choi; M-H Lee
Journal:  Int J Immunogenet       Date:  2010-12-22       Impact factor: 1.466

Review 5.  Public Health Burden and Epidemiology of Atopic Dermatitis.

Authors:  Jonathan I Silverberg
Journal:  Dermatol Clin       Date:  2017-04-22       Impact factor: 3.478

Review 6.  Filaggrin in atopic dermatitis: flaky tail mice as a novel model for developing drug targets in atopic dermatitis.

Authors:  Catharina Sagita Moniaga; Kenji Kabashima
Journal:  Inflamm Allergy Drug Targets       Date:  2011-12

Review 7.  Clinical Development of Histamine H4 Receptor Antagonists.

Authors:  Robin L Thurmond; Jennifer Venable; Brad Savall; David La; Sandra Snook; Paul J Dunford; James P Edwards
Journal:  Handb Exp Pharmacol       Date:  2017

8.  Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.

Authors:  Yoko Murata; Michael Song; Hisayuki Kikuchi; Katsuya Hisamichi; Xie L Xu; Andrew Greenspan; Mai Kato; Chiun-Fang Chiou; Takeshi Kato; Cynthia Guzzo; Robin L Thurmond; Mamitaro Ohtsuki; Masutaka Furue
Journal:  J Dermatol       Date:  2014-12-09       Impact factor: 4.005

9.  Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation.

Authors:  Kazushi Morimoto; Naritoshi Shirata; Yoshitaka Taketomi; Soken Tsuchiya; Eri Segi-Nishida; Tomoaki Inazumi; Kenji Kabashima; Satoshi Tanaka; Makoto Murakami; Shuh Narumiya; Yukihiko Sugimoto
Journal:  J Immunol       Date:  2013-12-16       Impact factor: 5.422

10.  Reactive Oxygen Species Mediated Prostaglandin E2 Contributes to Acute Response of Epithelial Injury.

Authors:  Yi-Ping Hu; Yin-Bo Peng; Yi-Fan Zhang; Ying Wang; Wei-Rong Yu; Min Yao; Xiu-Jun Fu
Journal:  Oxid Med Cell Longev       Date:  2017-02-09       Impact factor: 6.543
View more
  2 in total

1.  PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.

Authors:  Jiahui Zhao; Admire Munanairi; Xian-Yu Liu; Jie Zhang; Linghan Hu; Meiqin Hu; Dingfang Bu; Lingling Liu; Zhiqiang Xie; Brian S Kim; Yong Yang; Zhou-Feng Chen
Journal:  J Invest Dermatol       Date:  2020-01-29       Impact factor: 8.551

Review 2.  Critical Players and Therapeutic Targets in Chronic Itch.

Authors:  Hua Yang; Weiwei Chen; Renkai Zhu; Jiafu Wang; Jianghui Meng
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.